Cargando…

Management of Chronic Congestive Heart Failure Caused by Myxomatous Mitral Valve Disease in Dogs: A Narrative Review from 1970 to 2020

SIMPLE SUMMARY: Myxomatous mitral valve disease (MMVD) is the most common acquired cardiovascular disease in dogs. The progression of the disease and the increasing severity of valvular regurgitation cause a volume overload of the left heart, leading to left atrial and ventricular remodeling and con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bagardi, Mara, Zamboni, Viola, Locatelli, Chiara, Galizzi, Alberto, Ghilardi, Sara, Brambilla, Paola G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773235/ https://www.ncbi.nlm.nih.gov/pubmed/35049831 http://dx.doi.org/10.3390/ani12020209

Ejemplares similares

Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease
por: Galizzi, Alberto, et al.
Publicado: (2021)

A Genomic Study of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels
por: Bionda, Arianna, et al.
Publicado: (2020)

Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease
por: Bagardi, Mara, et al.
Publicado: (2022)

Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker
por: Savarese, Alice, et al.
Publicado: (2018)

Radiographic lung congestion scores in dogs with acute congestive heart failure caused by myxomatous mitral valve disease
por: Koster, Liza, et al.
Publicado: (2023)

Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease
por: Valente, Carlotta, et al.
Publicado: (2021)

Usefulness of Conventional and Tissue Doppler Echocardiography to Predict Congestive Heart Failure in Dogs with Myxomatous Mitral Valve Disease
por: Kim, J.‐H., et al.
Publicado: (2014)

Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study
por: Ghilardi, Sara, et al.
Publicado: (2022)

Myxomatous degeneration of the mitral valve
por: Neto, Felippe Lazar, et al.
Publicado: (2018)

Echocardiographic Evaluation of the Mitral Valve in Cavalier King Charles Spaniels
por: Bagardi, Mara, et al.
Publicado: (2020)

Prevalence and risk factors for atrial fibrillation in dogs with myxomatous mitral valve disease
por: Guglielmini, Carlo, et al.
Publicado: (2020)

Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease
por: Kim, H.‐S., et al.
Publicado: (2016)

Assessment of heart rate turbulence in dogs with myxomatous mitral valve disease
por: dos Santos, Julio P., et al.
Publicado: (2021)

Pro-Inflammatory and Immunological Profile of Dogs with Myxomatous Mitral Valve Disease
por: Piantedosi, Diego, et al.
Publicado: (2022)

Left Atrial Mural Thrombosis and Hemopericardium in a Dog with Myxomatous Mitral Valve Disease
por: Caivano, Domenico, et al.
Publicado: (2021)

Echocardiographic predictors of first onset of atrial fibrillation in dogs with myxomatous mitral valve disease
por: Baron Toaldo, Marco, et al.
Publicado: (2020)

Hemodynamic Effects of Protamine Infusion in Dogs with Myxomatous Mitral Valve Disease Undergoing Mitral Valvuloplasty
por: Yoshida, Tomohiko, et al.
Publicado: (2022)

The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs
por: Vezzosi, Tommaso, et al.
Publicado: (2021)

Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease
por: Borgarelli, M., et al.
Publicado: (2015)

Predictive model for the detection of pulmonary hypertension in dogs with myxomatous mitral valve disease
por: MIKAWA, Shoma, et al.
Publicado: (2014)

Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs
por: Nakamura, K., et al.
Publicado: (2017)

ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
por: Keene, Bruce W., et al.
Publicado: (2019)

Radiographic quantification of left atrial size in dogs with myxomatous mitral valve disease
por: Lam, Christopher, et al.
Publicado: (2021)

Serum Proteomic Profiles Reflect the Stages of Myxomatous Mitral Valve Disease in Dogs
por: Rešetar Maslov, Dina, et al.
Publicado: (2023)

Evaluation of progression of chronic kidney disease in dogs with myxomatous mitral valve disease
por: Yun, Hyejin, et al.
Publicado: (2023)

Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease
por: McManamey, Anna K., et al.
Publicado: (2023)

Cardiorenal and endocrine effects of synthetic canine BNP1‐32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease
por: Yata, Mariko, et al.
Publicado: (2019)

Myxomatous Mitral Valve with Prolapse and Flail Scallop
por: Fan, Jerry, et al.
Publicado: (2016)

Does the Cambridge classification alone predict the possibility to perform echocardiographic examination in lateral recumbency in dogs affected by brachycephalic obstructive airways syndrome?
por: Bagardi, Mara, et al.
Publicado: (2023)

Effect of prespecified therapy escalation on plasma NT‐proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease
por: Hezzell, Melanie J., et al.
Publicado: (2018)

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
por: Coffman, Melissa, et al.
Publicado: (2021)

Echocardiographic Estimates of Right Ventricular Systolic Function in Dogs with Myxomatous Mitral Valve Disease
por: Chapel, E.H., et al.
Publicado: (2017)

Sildenafil improves heart rate variability in dogs with asymptomatic myxomatous mitral valve degeneration
por: PIRINTR, Prapawadee, et al.
Publicado: (2017)

Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human
por: Markby, Greg R., et al.
Publicado: (2017)

Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity
por: Valente, Carlotta, et al.
Publicado: (2020)

The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease
por: Höglund, Katja, et al.
Publicado: (2020)

Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease
por: Sarcinella, Fabio, et al.
Publicado: (2019)

Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease
por: Druzhaeva, Natalia, et al.
Publicado: (2021)

Echocardiographic estimation of left ventricular‐arterial coupling in dogs with myxomatous mitral valve disease
por: Osuga, Tatsuyuki, et al.
Publicado: (2021)

Prognostic value of serum cystatin C concentration in dogs with myxomatous mitral valve disease
por: Iwasa, Naoki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vq9orgddk4q457p4uosmnv5ntc